Oleclumab
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Oleclumab, covering 2024-12-19 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer [Phase 2]